-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下：我们将Verizon未来12个月的目标股价上调10美元至50美元，并采用7.4倍的EV/EBITDA倍数对2026年的业绩进行估值，与同业平均水平相当。我们将Verizon 2026年的每股收益预期上调0.03美元至4.93美元，并将2027年的每股收益预期上调0.08美元至5.25美元。Verizon的扭亏为盈计划正在稳步推进并取得进展，这得益于一项旨在重塑运营和客户服务的全面转型计划。该转型计划使Verizon的核心运营指标在本季度表现强劲，并将业绩转化为十多年来未见的稳健运营和财务成果。考虑到这是丹·舒尔曼担任首席执行官后的第一个完整季度，这一成就令人印象深刻。由于业绩扭亏为盈，Verizon提高了其2026年调整后每股收益增长预期和后付费手机净新增用户数预期。我们注意到，仍有一些领域需要改进。尽管整体净新增用户数为正，但消费者后付费手机净流失用户数为3.5万部，这表明消费者业务领域仍面临挑战。
Related Articles
Research
Research Alert: Shell Agrees To Buy Arc Resources For Usd16.4b
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Shell announced the acquisition of ARC Resources for USD16.4B enterprise value, offering CAD32.80 per share (20% premium to 30-day VWAP) through 25% cash and 75% equity consideration, expected to close in 2H 2026. The transaction will immediately add 370 kboe/d production, representing a substantial 20% increase to Shell's current 1.8M boe/d output. We believe the deal establishes Canada as a core operating region and accelerates Shell's production CAGR from 1% to 4% through 2030. Management expects USD250M in annual synergies while maintaining USD20B-USD22B capex guidance and 40%-50% cash flow distribution policy. However, Shell is paying USD44k per boe/d at the higher range of recent Canadian E&P multiples, with 75% equity consideration diluting existing shareholders by 3% and delaying free cash flow accretion until 2027. In our view, value creation will depend on Shell achieving operational improvements materially beyond stated synergies while maintaining capital efficiency metrics.
$SHEL
Asia
EPS Creative Health Renews Product Purchase Framework With Parent-Linked Supplier
EPS Creative Health Technology (HKG:3860) unit EP Trading entered into a framework purchase agreement with EPS Americas to procure laboratory consumables for three years through March 2029, according to a Monday Hong Kong bourse filing.Shares of the firm were up nearly 2% in Tuesday morning trade.The agreement replaces a prior arrangement that expired on March 31 and covers products, including animal testing consumables such as purified diets, bedding, cages, and related supplies.Proposed annual caps are set at HK$33 million for 2027, HK$36 million for 2028, and HK$39 million for 2029.EPS Americas is a subsidiary of the company's controlling shareholder, EPS Holdings, the filing said.
$HKG:3860
Asia
Elsight Says Halo Connectivity Platform Granted US Blue List Status, Shares Up 5%
Elsight (ASX:ELS) said its Halo connectivity platform has been included in the US Department of War's Defense Contract Management Agency (DCMA) Blue List, a directory of approved National Defense Authorization Act (NDAA)-compliant unmanned aircraft systems and components, according to a Tuesday Australian bourse filing.The company said the clearance confirms that Halo meets the Department of War's standards for operational reliability, enabling US military units to procure Halo directly through the DCMA acquisition marketplace, bypassing traditional government acquisition cycles.The Blue List inclusion is expected to increase adoption and deployment velocity in US military and allied unmanned aircraft system (UAS) programs, the company added.The company's shares rose 5% in recent Tuesday trade.
$ASX:ELS